Impairment of brain function in a mouse model of Alzheimer's disease during the pre-depositing phase: the role of alpha7 nicotinic acetylcholine receptors
Olena Lykhmus, Wen-Yu Tzeng, Lyudmyla Koval, Kateryna Uspenska, Elizabeta Zirdum, Olena Kalashnyk, Olga Garaschuk, Maryna V. Skok
This study shows that in a mouse model of Alzheimer's disease, before amyloid deposition, there are increased inflammatory markers, reduced nicotinic acetylcholine receptors, and impaired memory, which can be mitigated by targeting alpha7 nAChRs.
Biomedicine & Pharmacotherapy · Aug 7, 2024Peer-reviewedNeuroscience